FDA approves Sage's first-ever treatment for postpartum depression
March 19, 2019 at 17:53 PM EDT
Zulresso is Sage's first product to reach the market and one of two treatments the company has developed to treat postpartum depression.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.